Business · 10/07/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Genetic Metabolic Diseases Advisory Committee for Arimoclomol New Drug Application
Summary
The FDA is hosting a public meeting of the Genetic Metabolic Diseases Advisory Committee to provide advice on a new drug application for Arimoclomol, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →